143 related articles for article (PubMed ID: 12013352)
1. Effect of milk thistle on the pharmacokinetics of indinavir in healthy volunteers.
Piscitelli SC; Formentini E; Burstein AH; Alfaro R; Jagannatha S; Falloon J
Pharmacotherapy; 2002 May; 22(5):551-6. PubMed ID: 12013352
[TBL] [Abstract][Full Text] [Related]
2. Coadministration of milk thistle and indinavir in healthy subjects.
DiCenzo R; Shelton M; Jordan K; Koval C; Forrest A; Reichman R; Morse G
Pharmacotherapy; 2003 Jul; 23(7):866-70. PubMed ID: 12885100
[TBL] [Abstract][Full Text] [Related]
3. Milk thistle and indinavir: a randomized controlled pharmacokinetics study and meta-analysis.
Mills E; Wilson K; Clarke M; Foster B; Walker S; Rachlis B; DeGroot N; Montori VM; Gold W; Phillips E; Myers S; Gallicano K
Eur J Clin Pharmacol; 2005 Mar; 61(1):1-7. PubMed ID: 15666173
[TBL] [Abstract][Full Text] [Related]
4. Effect of high-dose vitamin C on the steady-state pharmacokinetics of the protease inhibitor indinavir in healthy volunteers.
Slain D; Amsden JR; Khakoo RA; Fisher MA; Lalka D; Hobbs GR
Pharmacotherapy; 2005 Feb; 25(2):165-70. PubMed ID: 15767232
[TBL] [Abstract][Full Text] [Related]
5. Indinavir concentrations and antiviral effect.
Acosta EP; Henry K; Baken L; Page LM; Fletcher CV
Pharmacotherapy; 1999 Jun; 19(6):708-12. PubMed ID: 10391416
[TBL] [Abstract][Full Text] [Related]
6. Pharmacologic characteristics of indinavir, didanosine, and stavudine in human immunodeficiency virus-infected children receiving combination therapy.
Fletcher CV; Brundage RC; Remmel RP; Page LM; Weller D; Calles NR; Simon C; Kline MW
Antimicrob Agents Chemother; 2000 Apr; 44(4):1029-34. PubMed ID: 10722507
[TBL] [Abstract][Full Text] [Related]
7. The influence of efavirenz on the pharmacokinetics of a twice-daily combination of indinavir and low-dose ritonavir in healthy volunteers.
Aarnoutse RE; Grintjes KJ; Telgt DS; Stek M; Hugen PW; Reiss P; Koopmans PP; Hekster YA; Burger DM
Clin Pharmacol Ther; 2002 Jan; 71(1):57-67. PubMed ID: 11823758
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic drug-drug interaction study of delavirdine and indinavir in healthy volunteers.
Ferry JJ; Herman BD; Carel BJ; Carlson GF; Batts DH
J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Jul; 18(3):252-9. PubMed ID: 9665503
[TBL] [Abstract][Full Text] [Related]
9. Alteration in indinavir clearance during interleukin-2 infusions in patients infected with the human immunodeficiency virus.
Piscitelli SC; Vogel S; Figg WD; Raje S; Forrest A; Metcalf JA; Baseler M; Falloon J
Pharmacotherapy; 1998; 18(6):1212-6. PubMed ID: 9855318
[TBL] [Abstract][Full Text] [Related]
10. Antiviral effect and pharmacokinetic interaction between nevirapine and indinavir in persons infected with human immunodeficiency virus type 1.
Murphy RL; Sommadossi JP; Lamson M; Hall DB; Myers M; Dusek A
J Infect Dis; 1999 May; 179(5):1116-23. PubMed ID: 10191212
[TBL] [Abstract][Full Text] [Related]
11. Steady-state pharmacokinetic interaction of modified-dose indinavir and rifabutin.
Hamzeh FM; Benson C; Gerber J; Currier J; McCrea J; Deutsch P; Ruan P; Wu H; Lee J; Flexner C;
Clin Pharmacol Ther; 2003 Mar; 73(3):159-69. PubMed ID: 12621381
[TBL] [Abstract][Full Text] [Related]
12. A pharmacokinetic drug-drug interaction study of venlafaxine and indinavir.
Levin GM; Nelson LA; DeVane CL; Preston SL; Eisele G; Carson SW
Psychopharmacol Bull; 2001; 35(2):62-71. PubMed ID: 12397887
[TBL] [Abstract][Full Text] [Related]
13. Safety and toxicity of silymarin, the major constituent of milk thistle extract: An updated review.
Soleimani V; Delghandi PS; Moallem SA; Karimi G
Phytother Res; 2019 Jun; 33(6):1627-1638. PubMed ID: 31069872
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of indinavir at 800, 600, and 400 milligrams administered with ritonavir at 100 milligrams and efavirenz in ethnic chinese patients infected with human immunodeficiency virus.
Lee LS; Panchalingam A; Yap MC; Paton NI
Antimicrob Agents Chemother; 2004 Nov; 48(11):4476-8. PubMed ID: 15504888
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and metabolic profile of free, conjugated, and total silymarin flavonolignans in human plasma after oral administration of milk thistle extract.
Wen Z; Dumas TE; Schrieber SJ; Hawke RL; Fried MW; Smith PC
Drug Metab Dispos; 2008 Jan; 36(1):65-72. PubMed ID: 17913795
[TBL] [Abstract][Full Text] [Related]
16. Effect of fluconazole on indinavir pharmacokinetics in human immunodeficiency virus-infected patients.
De Wit S; Debier M; De Smet M; McCrea J; Stone J; Carides A; Matthews C; Deutsch P; Clumeck N
Antimicrob Agents Chemother; 1998 Feb; 42(2):223-7. PubMed ID: 9527763
[TBL] [Abstract][Full Text] [Related]
17. What's in a name?
Bell W
Can Fam Physician; 2008 Feb; 54(2):183, 185. PubMed ID: 18272627
[No Abstract] [Full Text] [Related]
18. Effect of milk thistle (Silybum marianum) and black cohosh (Cimicifuga racemosa) supplementation on digoxin pharmacokinetics in humans.
Gurley BJ; Barone GW; Williams DK; Carrier J; Breen P; Yates CR; Song PF; Hubbard MA; Tong Y; Cheboyina S
Drug Metab Dispos; 2006 Jan; 34(1):69-74. PubMed ID: 16221754
[TBL] [Abstract][Full Text] [Related]
19. RATIONALIZED AND COMPLEMENTARY FINDINGS OF SILYMARIN (MILK THISTLE) IN PAKISTANI HEALTHY VOLUNTEERS.
Ashraf M; Abid F; Riffat S; Bashir S; Iqbal J; Sarfraz M; Afzal A; Zaheer M
Acta Pol Pharm; 2015; 72(3):607-14. PubMed ID: 26642669
[TBL] [Abstract][Full Text] [Related]
20. Effects of didanosine formulations on the pharmacokinetics of amprenavir.
Shelton MJ; Giovanniello AA; Cloen D; Berenson CS; Keil K; DiFrancesco R; Hewitt RG
Pharmacotherapy; 2003 Jul; 23(7):835-42. PubMed ID: 12885096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
